chrisvoncsefalvay/vaers-outcomes huggingface dataset:
NASAL CONGESTION; This spontaneous report received from a patient concerned a 50 year old female. The patient's weight was 52.3 kilograms, and height was not reported. The patient's concurrent conditions included seasonal allergies, and secondary pulmonary hypertension. The patient received epoprostenol sodium (injection, intravenous, batch number: MM254M0101 expiry: UNKNOWN) dose, frequency, and therapy dates were not reported for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included ambrisentan for drug used for unknown indication, and tadalafil non-company for drug used for unknown indication. On an unspecified date, the subject experienced nasal congestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and dose of epoprostenol sodium was not changed. The outcome of nasal congestion was not reported. This report was non-serious.
felt like I had the flu for a day; This case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Shingles vaccine (had single shot version first with no problems) and Shingles vaccine with an associated reaction of influenza like illness (1st dose received on an unknown date, for tolerance refer linked case US2021AMR048213).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza-like symptoms. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group at vaccination was not reported but was captured as an adult as per vaccine indication. The patient felt like the flu for a day after vaccination. The patient already had Shingles in past and never want again. For tolerence with 1st dose refer case US2021AMR048213; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR048213:same reporter 2nd dose
Client presented to RA Team on 08/14/22. The client notified that she had received a Janssen vaccine Lot#182j281 as her primary series on 06/17/2021. She received a Pfizer first booster Lot# FJ8757 on 12/19/21 at Pharmacy and received a Pfizer second booster Lot#FK9895 on 5/1/22 at Public Health Center. Lead sent a text messaged to supervisor regarding the three vaccines the client received. Per supervisor and CDC guidance, it shows that she should not have received a Pfizer second booster since she does not meet the criteria. Client reported that she is not immunocompromised, and no medical consult was done at the time when she got her Pfizer second booster. Client also reported having her documentation for Janssen and first Pfizer booster when she came in for the Pfizer second booster. Client reported no adverse reactions to Pfizer second booster.  Was unable to obtain medical history and known allergies from the client. Educated client that she is complete with her primary series and boosters.
Following day, the injection site was sore, raised, red and swollen & warm to touch, headache, tiredness; three days later I had chills and elevated temperature for about 3 hours then it subsided; 10 days later my injection site finally recovered, and then my skin around the injection site started peeling.
Covid19 second vaccination adverse reaction: Received vaccination at 0815am Tuesday 1/12. By 6pm, onset of rigors/chills, body aches, generalized malaise, fatigue, headache which lasted until Wednesday 1/13 ~11:30pm (only x1 low grade fever 99.2 ~6pm Wednesday). Thursday 1/14 called out sick from work residual exhaustion/fatigue and minor headache, body aches dissipated. Able to return to work Friday 1/15.
Patient received Prevnar 13 exposed to temperature excursion; Patient received Prevnar 13 exposed to temperature excursion; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This is the 1st of 2 reports. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration, on an unspecified date, at single dose, for immunisation. Medical history and concomitant medications were not reported. The patient received Prevnar 13 exposed to temperature excursion. It was reported that temperature excursion occurred in Sep2019.   The information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020123171 Same reporter/drug/event, different patient
On the 3rd. day after injection  felt very dizzy for 1/2 day .   On 4th. day after injection still felt dizzy in morning but went away after about 2 hours.  On  5h. and 6 th. day feeling in general all day light-headed.
got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell). At the time of the report, COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not reported.  Patient had COVID -19 around 3 weeks ago.   This case was linked to MOD-2021-297213 (Patient Link).
About 1 hour after vaccine I experienced a severe headache, low grade fever and chills.  Two hour after injection I experienced a sudden onset of sever tingling and numbness in my left foot, leg, arm and hand which rapidly got worse.  I had trouble stepping on the foot and walking.  I decided to rest for the remainder of the day and called my primary care physician the following day.  I never received a call back from her as promised and called again by end of day around 5pm CT to be told by the front desk to go to the ER.  I held off from doing so for financial reasons and decided to make an appointment with an neurologist instead.  Today (day 3 after the vaccination my symptoms are still present but have not worsened).  I am still very concerned to potentially develop paralysis or GBS and therefore wanted to report the issue.
Topical allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Topical allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Topical allergic reaction). At the time of the report, HYPERSENSITIVITY (Topical allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Adult received pediatric dose; Adult received pediatric dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 34-year-old male patient who received HAV (Havrix pediatric) for prophylaxis.   On 19-APR-2023, the patient received Havrix pediatric .5 ml. On 19-APR-2023, an unknown time after receiving Havrix pediatric, the patient experienced underdose (Verbatim: Adult received pediatric dose) and adult use of a child product (Verbatim: Adult received pediatric dose). The outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-APR-2023 The registered nurse reported that the patient received a pediatric dose of Havrix. The reporter called to inquire how to proceed with Havrix and would patient need one ml. The reporter did not consent to follow up. The adult patient received a dose of Havrix pediatric, which led to underdose and adult use of a child product.
Admitted for placenta previa in third trimester. C-section on 12/2/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
The pt's left thigh was enlarged, red, raised around the vaccine injection site with a firm nodule. Non-tender. Treated with Benadryl.
Tingle left side of jaw, negative assessment  BP stable . Tingle resolved. pt left with wife
Patient admitted ~3 days post COVID vaccine with hematuria/lower GI bleeding. Unclear if related to vaccine or prior noted history.
Patient got Janssen vaccinc , 5 minutes later his sister told us he was getting head ache ..got him water , headache he stated was getting worse throbbing pain, gave ice pack. as he was drinking bottle water , pt started leaning over as if sick, noticed blood coming from right nasal and he was actually about to pass out.got him sitting up while sister sat with him on phone with mother. Called 911 .pt was soaked with perspiration.He told EMT his vision was blurry but slowly coming back. After EMT assessed him he was starting to feel better  and started walking and his oxygen was back up. Mom met with EMT later.
Hospitalized with COVID 19 pneumonia.  Had received 2 vaccines and a booster.
pt recvd vax 26MAR92 AM, fever 26MAR & 27MAR 100 R, irritable given APAP; mom not caregiver on weekend-event?; seen by MD 30MAR r/o rxn to vax; ?ear involvement; 30MAR-31MAR limbs purplish "cyanotic, nose clogged;
This spontaneous report was received from a nurse refers to a 22 year old male patient. The medical history, concurrent conditions and concomitant medications were not reported. On APR-2016 the patient was vaccinated with first dose of GARDASIL lot # L040459, 06-APR-2017 for prophylaxis. On OCT-2016, the patient was vaccinated with second dose of GARDASIL 9 lot#M018810 28-MAY-2018. The patient had not yet received the last dose in the series. No adverse effects reported. Additional information has been requested.
Began having increased confusion on 10/15/21. On 10/16 resident tearful with mild tremors and increased anxiety. Sent to ER r/t AMS and increased TSH. Returned to facility. On 10/19, resident admitted to the hospital due to vomiting, AMS, dizziness.
Patient is a critical care physician who received inactivated flu shot 18 OCT who awakened 27 OCT with left eye ptosis, erythema, and double vision. Diagnosed with ocular myasthenia gravis. MRI and CT normal. Ach receptor binding antibody titer very high. Symptoms persist and are worse at end of day. Prior flu vaccines have been Flumist.
With in 10 min of immunizations admin. Patient sites bilat swelled, hot to touch with redness, measured <MMR left VL 25mm x 17mm> <varicella lower right VL 38mm x 29mm> Dr. evaluated patient; No concerns-Lungs clear.
Five macular-urticarial rash over trunk arms and legs, no mucous membrane instead mildy pruritic.
Strange sensation on my tongue and a strange taste almost like antibiotic drops in your eyes. Lasted for 2 days. I am scared for the next dose. Please advise me if I should take Benadryl 2 hours before I get the vaccine?
2 weeks after receiving vaccine patient was hospitalized due to congestive heart failure and pneumonia.
initial report received from a consumer who is also the patient on 19 OCTOBER 2012. A 30-year-old female patient, with no  relevant medical history, whose concomitant medications were not reported, had received FLUZONE (lot number UH4720AB, route of administration was not reported) in left arm on 15 OCTOBER 2012. On 16 OCTOBER 2012, 1 day after vaccination, the patient presented with vomiting and severe headache every evening since then. The corrective treatments and laboratory investigations were not reported. At the time of this report, the patient had not recovered from the events. Documents held by sender: None.
Child becomes inconsolable 24 hours following vaccination. No rash, fever, itching, swelling, nausea, vomiting were observed. Symptoms resolved after 8 hrs. Crying was described as screaming/wailing.
I'm going to die; his head is a little dizzy; Dry mouth; Continuous headache; Throwing up; Losing weight; Taste buds are off; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Apr2021 (at 52-year-old) (Lot Number: ER8732) as dose 2, single in arm left for COVID-19 immunisation. The patient's medical history, family Medical History and other products were reported as none. The patient reported he was perfectly healthy before the COVID-19 shot (he worked out every day and rides his bike). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 26Mar2021 (at 52-year-old) (Lot Number: ER8730) as dose 1, single in left arm for COVID-19 immunisation.  The patient mentioned that "a week after, his taste buds are off in Apr2021, he had headache began Jun2021 (about a month ago), lost 40 pounds from a week after the second dose (Apr2021) in the last 2 months because he can't eat animals or dry food, he can't eat; and his head was a little dizzy because it made him throw up began maybe 30 days after receiving the Covid-19 vaccine (May2021) and it has stayed the same ". Caller wanted to know if anybody "reported about the loss of sense of taste and dry mouth since he has had a really dry mouth in Jun2021 as well and barely eating anything ". The only thing he is eating right now was tomato juice, yogurt, and soup. Caller mentioned that he was "still losing weight". When returned from hold, caller mentioned he was "taking a headache medicine" and Tylenol 500 mg at the time. Caller mentioned that he was over 200 pounds and after the vaccine, he lost 40 pounds, and weight loss was getting worse and worse. He's already down to 160 pounds. (probably be down to 130). He was going to die/ probably die soon. "Taste buds are off" was reported as worsened. He went to the emergency room 2 weeks ago and a specialist. Emergency room doctor gave him metoclopramide and he was taking 3 per day. He was being sent for a CT scan and was going to the ear, nose, and throat doctor this month (Jul2021). His physician referred him to gastro health and he went there yesterday, 07Jul2021. He still has a little headache, sort of like a 304 on the pain scale with the meds. Tylenol and metoclopramide do bring his headache down some. The outcome of events near death experience, dizzy was unknown; of events loss of taste, headache, weight decreased, vomiting, dry mouth was not resolved.
Complained of redness and swelling at vaccination site. Complained of "heat" at area. 11/20/04 went to Treatment Center . S/B MD . Treated with Keflex and Benadryl.
long-lasting headache (still present at time of report), pressure in temples, occasional short (3-5 seconds) stabbing pain in left temple 5-10 times daily. On day of reporting (11/10) stabbing pain is less frequent (4 times today) but pressure in both temples is persistent.
flu nearly dead; Ended up with long term respiratory issues; Ended up with long term nerve issues; Initial information was received on 07-Nov-2020 regarding an unsolicited valid serious case from a consumer (patient) via social media.  This case involves a patient with unknown demography who took the flu shot and ended up in the hospital with the flu nearly dead (influenza) and ended up with long term respiratory and nerve issues (respiratory disorder) (Nervous system disorder), while the patient received INFLUENZA VACCINE.  Medical history, past medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (Produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced serious flu nearly dead (influenza), ended up with long term respiratory and nerve issues (respiratory disorder) (Nervous system disorder) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for these events.  Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the events was unknown at the time of reporting.  Batch number has been requested for suspect product for this case.; Sender's Comments: This poorly document case received from social media concerns a patient with unknown demography who experienced  flu nearly death and long term respiratory and nerve issues, after vaccination with INFLUENZA VACCINE, produced by unknown manufacturer. The time to onset is unknown. However, patient's medical condition at time of vaccination and lab test ruling out alternate etiologies were not reported. Based upon the reported information the role of vaccine cannot be assessed.
Injection site pain; Inability to lift arm; Dizzy; Anxiety; Chills; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 23Nov2021 at 14:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Concomitant medications included levothyroxine sodium (SYNTHROID), metformin (MANUFACTURER UNKNOWN) and norethisterone acetate/ ethinylestradiol (AUROVELA); all for unknown indications from unknown dates and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Nov2021 at 21:00, the patient experienced injection site pain, inability to lift arm, dizzy, anxiety and chills. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, inability to lift arm, dizzy, anxiety and chills was not resolved at the time of the report. No follow-up attempts are possible. No further information is expected.
About an hour after receiving my second dose of the Shingrix vaccine I had swelling and pain at the injection site and by 13 hours after my second dose the injection site on my left arm also had a red rash that was about 4 inches long by 2  inches wide.  Also, at about 13 hours after receiving my second dose, I developed a severe headache, felt dizzy, my heart was pounding, I had the chills and was shivering.  I also felt very tired and by 17 hours out I threw up and at 24 hours out I threw up again.  By 36 hours out from my second dose I still had an upset stomach but was able to hold some food down and by about 52 hours out I was feeling pretty much back to normal.
On 21st Apr 2021, Patient mentioned as waking up super tired and feverish; On 21st Apr 2021, Patient mentioned as waking up super tired and feverish; on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness; on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness; on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness; Felt like passing out; Dizziness; Vomiting; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Felt like passing out), DIZZINESS (Dizziness), VACCINATION SITE PRURITUS (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness), VOMITING (Vomiting) and NAUSEA (nausea) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced DIZZINESS (Dizziness), VOMITING (Vomiting) and NAUSEA (nausea). On 10-Apr-2021, the patient experienced PRESYNCOPE (Felt like passing out). On 20-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness), VACCINATION SITE RASH (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness) and VACCINATION SITE ERYTHEMA (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness). On 21-Apr-2021, the patient experienced FATIGUE (On 21st Apr 2021, Patient mentioned as waking up super tired and feverish) and PYREXIA (On 21st Apr 2021, Patient mentioned as waking up super tired and feverish). At the time of the report, PRESYNCOPE (Felt like passing out), DIZZINESS (Dizziness), VACCINATION SITE PRURITUS (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness), VOMITING (Vomiting), NAUSEA (nausea), VACCINATION SITE RASH (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness), VACCINATION SITE ERYTHEMA (on 20th Apr 2021 she developed injection site reactions on the right arm as rash, itchy and redness), FATIGUE (On 21st Apr 2021, Patient mentioned as waking up super tired and feverish) and PYREXIA (On 21st Apr 2021, Patient mentioned as waking up super tired and feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.  Treatment information was not reported.   Reporter did not allow further contact
This is a spontaneous report from a contactable pharmacist.  A 71-years-old female patient received PREVNAR 13; (lot number M79319, expiration date Aug2017), via an unspecified route of administration, on 03Oct2016 11:00 as single dose for immunisation.  Medical history included egg allergy. Other No other medical conditions were reported. There were no concomitant medications. The patient previously took influenza vaccine for immunisation and was allergic.  The patient experienced hives on 03Oct2016. The details were described as follows: Pharmacist gave the patient the vaccine today and the patient stated that she had hives around where the shot is given. No lab tests were reported. The action taken with pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) was not applicable. Therapeutic measures were taken as a result of hives; patient took BENADRYL. The outcome of hives was unknown. The reporting pharmacist reported yes for causality.